References

Filters: Author is Sarrazin, C  [Clear All Filters]
S
Sarrazin C, Isakov V, Svarovskaia ES. Late relapse versus hepatitis C virus reinfection in patients with sustained virologic response after sofosbuvir-based therapies. Clin Infect Dis. 2017;64(1):44-52.
Sarrazin C, Cooper CL, Manns MP, et al. No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients. J Hepatol. 2018;69(6):1221-1230. doi:10.1016/j.jhep.2018.07.023.
Top